Skip to content

Clinical trials

Hemoglobinopathies trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinopathies Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20171
20182
20213
20223
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Enrolling by invitation2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated4
Editas Medicine, Inc.3
Forma Therapeutics, Inc.2
Biossil Inc.1
Novartis Pharmaceuticals1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinopathies12
Hematologic Diseases9
Anemia, Sickle Cell8
Genetic Diseases, Inborn8
beta-Thalassemia6
Anemia5
Anemia, Hemolytic5
Thalassemia4
Anemia, Hemolytic, Congenital3
Hemolysis2

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.